Showing results (191-200 of 198) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Nature Microbiology|March 1, 2024
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host diseaseSarah Lindner, Oriana Miltiadous, Ruben J F Ramos, et al.JCI Insight|February 15, 2017
An early-biomarker algorithm predicts lethal graft-versus-host disease and survivalMatthew J Hartwell, Umut Özbek, Ernst Holler, et al.Blood|March 17, 2018
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHDHannah Major-Monfried, Anne S Renteria, Attaphol Pawarode, et al.Blood Advances|December 10, 2019
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host diseaseHrishikesh K Srinagesh, Umut Özbek, Urvi Kapoor, et al.Cell Host & Microbe|August 30, 2024
Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host diseaseEiko Hayase, Tomo Hayase, Akash Mukherjee, et al.Science Translational Medicine|November 16, 2022
Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatmentZaker I Schwabkey, Diana H Wiesnoski, Chia-Chi Chang, et al.Nature Medicine|April 11, 2018
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.Nature Medicine|February 13, 2018
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNimitha R Mathew, Francis Baumgartner, Lukas Braun, et al.Pageof 20